The Patent Finder

Nanocyte Inc.

Also on record
Records under this name other than patents Nanocyte Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Nanocyte Inc.

PatentTitleStatus Expires Confidence
US 8,337,868Stinging Cells Expressing an Exogenous Polynucleotide Encoding a Therapeutic, Diagnostic or a Cosmetic Agent and Methods Compositions and Devices Utilizing Such Stinging Cells or Capsules Derived Therefrom for Delivering the Therapeutic, Diagnostic or Cosmetic Agen
Term ended
Ended no later than Apr 19, 2024 · Medium confidence
Term endedEnded no later than Apr 19, 2024Medium confidence
US 8,834,862Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
Formerly held
Lapsed on the fee record
Ended Sep 16, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 16, 2022From the USPTO record
US 6,923,976Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering Therapeutic or a Cosmetic Agent into a Tissue
Term ended
Term ended Jul 7, 2022 · High confidence
Term endedTerm ended Jul 7, 2022High confidence
US 7,611,723Stinging Cells Expressing an Exogenous Polynucleotide Encoding a Therapeutic, Diagnostic or a Cosmetic Agent and Methods Compositions and Devices Utilizing Such Stinging Cells or Capsules Derived Therefrom for Delivering the Therapeutic, Diagnostic or Cosmetic Agen
Lapsed on the fee record
Ended Nov 3, 2021 · High confidence
Lapsed on the fee recordEnded Nov 3, 2021High confidence
US 6,613,344Methods Utilizing Stinging Cells/Capsules
Term ended
Term ended Sep 27, 2021 · High confidence
Term endedTerm ended Sep 27, 2021High confidence
US 7,632,522Use of stinging cells/capsules for the delivery of active agents to keratinous substances
Term ended
Ended no later than Sep 27, 2021 · From the USPTO record
Term endedEnded no later than Sep 27, 2021From the USPTO record
US 8,486,441Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering a Therapeutic or a Cosmetic Agent into a Tissue
Lapsed on the fee record
Ended Jul 16, 2021 · Medium confidence
Lapsed on the fee recordEnded Jul 16, 2021Medium confidence
US 8,287,912Use of stinging cells/capsules for the delivery of active agents to keratinous substances
Lapsed on the fee record
Ended Oct 16, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 16, 2020From the USPTO record
US 7,338,665Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering a Therapeutic or a Cosmetic Agent into a Tissue
Lapsed on the fee record
Ended Mar 4, 2020 · High confidence
Lapsed on the fee recordEnded Mar 4, 2020High confidence
US 8,062,660Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering a Therapeutic or a Cosmetic Agent into a Tissue
Lapsed on the fee record
Ended Nov 22, 2019 · High confidence
Lapsed on the fee recordEnded Nov 22, 2019High confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited